Inspira™ announces plans to report the primary results for a core blood oxygenation technology within days

The major milestone refers to inspira's proprietary technology to oxygenate blood for the inspira™ art (gen 2). this patented tech is considered by inspira to be a game-changer and also aims to replace technologies used today by current medical device companies.
IINN Ratings Summary
IINN Quant Ranking